Actively Recruiting

Phase 3
Age: 18Years - 85Years
FEMALE
NCT04789694

Prehabilitation in Gynaecological Cancer Patients

Led by Charles University, Czech Republic · Updated on 2026-03-19

64

Participants Needed

1

Research Sites

283 weeks

Total Duration

On this page

Sponsors

C

Charles University, Czech Republic

Lead Sponsor

U

University Hospital Ostrava

Collaborating Sponsor

AI-Summary

What this Trial Is About

Prehabilitation refers to interventions aiming to improve patients' resilience and functional capacity before a known stressful event, e.g., scheduled surgery. These interventions usually consist of physical activity and psychological and nutritional support. There is substantial evidence of the positive effect of multimodal prehabilitation among patients treated surgically for non-gynaecological cancers; however, no prospective data are available in gynaecological cancer patients. PHOCUS trial is a prospective randomised trial aiming to evaluate the role of multimodal prehabilitation in patients with gynaecological cancer. Sixty-four patients will be randomised in single institution within 36 months with a 1:1 ratio into ARM A: control arm which will be provided with a basic information and standard of care support; ARM B: active arm undergoing multimodal prehabilitation composed of physical activity and psychological and nutritional support. All patients will be assessed at standard intervals (three times during the trial) by a spectrum of non-invasive tests, evaluating physical functional capacity, postoperative morbidity, nutritional status, level of stress and anxiety, and quality of life.

CONDITIONS

Official Title

Prehabilitation in Gynaecological Cancer Patients

Who Can Participate

Age: 18Years - 85Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female patients with epithelial ovarian cancer referred for neoadjuvant chemotherapy who meet all: FIGO stage III or IV; not candidates for primary debulking surgery; suitable for combined chemotherapy; candidates for interval debulking surgery
  • Female patients with stage I or II endometrial cancer classified as frail by modified Frailty Index
  • Endometrial cancer patients suitable for hormonal therapy
  • Patients planned for postponed surgical treatment
Not Eligible

You will not qualify if you...

  • Presence of a second malignant tumor currently under treatment
  • Patients not suitable for any surgery delay
  • Patients physically unable to follow the prehabilitation plan or unable to walk

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Gynecologic Oncology Center in Prague

Prague, Czechia, 12000

Actively Recruiting

Loading map...

Research Team

J

Jana Stribrna

CONTACT

S

Stefan Lednicky, MD.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Prehabilitation in Gynaecological Cancer Patients | DecenTrialz